Reduced Intensity Versus Myeloablative Conditioning Allogeneic HCT for Relapsed/Refractory Lymphoma: Applying Refined Disease Risk Index (DRI) to Improve Survival
Lazaryan, Aleksandr, Bachanova, Veronika, Cao, Qing, Lee McClune, Brian, Arora, Mukta, Mehta, Rohtesh S., Wagner, John E., Brunstein, Claudio G., Weisdorf, Daniel J., Bejanyan, NelliVolume:
22
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2015.11.631
Date:
March, 2016
File:
PDF, 187 KB
english, 2016